Manufacturer Recalls Millions of Insulin Syringes
Accusure Needles May Detach During Use
By News Staff
10/28/2009
The company said in a press release posted on the FDA Web site that the syringes were distributed nationwide to wholesale and retail pharmacies. Affected products have the following descriptions and national drug codes:
- 28G 1/2cc, NDC 0603-6995-21;
- 28G 1cc, NDC 0603-6996-21;
- 29G 1/2cc NDC 0603-6997-21;
- 29G 1cc, NDC 0603-6998-21;
- 30G 1/2cc, NDC 0603-999-21;
- 30G 1cc, NDC 0603-7000-21;
- 31G 1/2cc, NDC 0603-7001-21; and
- 31G 1cc, NDC 0603-7002-21.
Consumers who have Accusure insulin syringes should stop using them and contact Qualitest at (800) 444-4011 for reimbursement. The company said it is notifying customers who received the syringes and is arranging for the return of affected products.
As always, adverse reactions or quality problems may be reported to the FDA's MedWatch Safety Information and Adverse Event Reporting Program.
Recent Decline in U.S. Smoking Prevalence Stalls
USPSTF Revamps Breast Cancer Screening Recommendations
New Report Sounds 'Call to Revolutionize Chronic Pain Care'
AAFP Offers Guidance on FDA Tobacco Regulation
Focus Groups Reveal Physician Concerns About Comparative Effectiveness Research
Manufacturer Recalls Millions of Insulin Syringes
Second Grant to be Used for More Children's Healthy Lifestyles Books
AAFP, Others Reiterate Need for Flu Vaccines in Pregnant Women
Study Suggests Cost for Universal Coverage Misleading
FDA Warns of Adverse Events With Gentamicin Ophthalmic Ointment Use
AAFP, Other Organizations Urge Pregnant Women to Get Flu Vaccines
Physicians Should Recall Children in Need of Hib Booster Dose
FDA: Recalls, Market Withdrawals & Safety Alerts








